TARGIT IORT for breast cancer at higher risk of local recurrence

Eligible for TARGIT-B randomised trial

Discuss in multidisciplinary team

 

Offer Randomisation in the TARGIT-B (boost) trial

or

Use TARGIT boost instead of EBRT boost

 

or

If the patient

a) cannot take EBRT (lives far or other reasons)

and

 b) does not accept a mastectomy

then and only then

use TARGIT IORT instead of EBRT within an ethically approved prospective cohort study or randomised trial (TARGIT-X)

 

 

Back to first page

 

Back